CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Congenital clubfoot
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Claw hand
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Proximal muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Congenital kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Distal muscle weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Kyphoscoliosis deformity of spine
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acquired Kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Distal sensory impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Distal amyotrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Axonal regeneration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased number of peripheral myelinated nerve fibers
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased motor nerve conduction velocity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2K, MODIFIER OF (1 family)
|
0.100 |
SusceptibilityMutation
|
phenotype |
CLINVAR |
|
|
|
Narcolepsy
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association database developed in the Japanese Integrated Database Project.
|
19629137 |
2009 |
Charcot-Marie-Tooth Disease
|
0.060 |
Biomarker
|
disease |
BEFREE |
Mutations in the ganglioside-induced-differentiation-associated protein 1 gene (GDAP1) can cause Charcot-Marie-Tooth (CMT) disease with demyelinating (CMT4A) or axonal forms (CMT2K and ARCMT2K).
|
21199105 |
2010 |
Polyneuropathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
MIDs in which polyneuropathy is the dominant feature, include NARP syndrome due to the transition m.8993T>, CMT2A due to MFN2 mutations, CMT2K and CMT4A due to GDAP1 mutations, and axonal/demyelinating neuropathy with external ophthalmoplegia due to POLG1 mutations.
|
21402391 |
2011 |
Charcot-Marie-Tooth Disease
|
0.060 |
Biomarker
|
disease |
BEFREE |
Junctophilin-1 is a modifier gene of GDAP1-related Charcot-Marie-Tooth disease.
|
25168384 |
2015 |
Charcot-Marie-Tooth Disease
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth (CMT) disease caused by mutations in the GDAP1 gene has been shown to be inherited via traits that may be either autosomal recessive (in the majority of cases) [CMT4A] or autosomal dominant [CMT2K].
|
25337607 |
2014 |
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
CMT4A disease is characterized by an early onset, and a severe clinical course often leading to a loss of ambulation, whereas CMT2K is characterized by a mild clinical course of benign axonal neuropathy beginning even in the 6th decade of life.
|
25337607 |
2014 |
Charcot-Marie-Tooth Disease
|
0.060 |
Biomarker
|
disease |
BEFREE |
GDAP1 mutations also alter fission, fusion and transport of mitochondria and are associated either with recessive demyelinating (CMT4A) and axonal CMT (AR-CMT2K) and, less commonly, with dominant, milder, axonal CMT (CMT2K).
|
25847151 |
2015 |
Charcot-Marie-Tooth Disease
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) cause rare subtypes of Charcot-Marie-Tooth disease (CMT2K and CMT4A).
|
28495047 |
2017 |
Axonal neuropathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
CMT2K is an axonal neuropathy while CMT4A is a demyelinating type.
|
28495047 |
2017 |
Charcot-Marie-Tooth Disease
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K).
|
29372391 |
2018 |